A cluster-randomized, placebo-controlled trial to evaluate the efficacy of a spatial repellent (Mosquito Shield ™) against Aedes-borne virus infection among children ≥ 4–16 years of age in the Gampaha District, Sri Lanka: study protocol (the AEGIS program)

DiscussionThe trial will serve as an efficacy assessment of SR products in South Asia. Results will be submitted to the World Health Organization Vector Control Advisory Group for assessment of public health value towards an endorsement to recommend inclusion of SRs in ABV control programs.Trial registrationSri Lanka Clinical Trial RegistrySLCTR/2022/018. Registered on July 1, 2022.ClinicalTrials.govNCT05452447. Registered on July 11, 2022.The Universal Trial Number is U1111-1275-3055.
Source: Trials - Category: Research Source Type: clinical trials